We are live on ! Find out more
COCP icon

Cocrystal Pharma
COCP

35 hedge funds and large institutions have $9.78M invested in Cocrystal Pharma in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

0.02% less ownership

Funds ownership: 1.31% → 1.29% (-0.02%)

15% less funds holding

Funds holding: 41 → 35 (-6)

39% less capital invested

Capital invested by funds: $16.1M → $9.78M (-$6.28M)

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
35
Holders Change
-6
Holders Change %
-14.63%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
10
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$488K
2
JP Morgan Chase
JP Morgan Chase
New York
+$50.2K
3
UBS Group
UBS Group
Switzerland
+$19.8K
4
LPL Financial
LPL Financial
California
+$18.6K
5
TSS
Two Sigma Securities
New York
+$18.5K

Top Sellers

Rank Fund Capital Flow
1
Mariner
Mariner
Kansas
-$315K
2
Millennium Management
Millennium Management
New York
-$143K
3
Goldman Sachs
Goldman Sachs
New York
-$120K
4
Citadel Advisors
Citadel Advisors
Florida
-$114K
5
Renaissance Technologies
Renaissance Technologies
New York
-$106K
Name Holding Trade Value Shares
Change 		Change in
Stake
LODC
26
Lanham O'Dell & Company
West Virginia
$8K +$10.2K +1,000 New
CYG
27
Clean Yield Group
Vermont
$3K – – –
NL
28
NVWM LLC
Pennsylvania
$1K – – –
AIC
29
Archer Investment Corporation
Indiana
$650 – – –
Mariner
30
Mariner
Kansas
– -$315K -25,005 Closed
Millennium Management
31
Millennium Management
New York
– -$143K -11,353 Closed
Citadel Advisors
32
Citadel Advisors
Florida
– -$114K -9,028 Closed
HighTower Advisors
33
HighTower Advisors
Illinois
– -$66K -5,250 Closed
Qube Research & Technologies (QRT)
34
Qube Research & Technologies (QRT)
United Kingdom
– -$28K -2,210 Closed
Barclays
35
Barclays
United Kingdom
– -$22.6K -2,209 -99%
VF
36
Virtu Financial
New York
– -$20K -1,561 Closed
CL
37
CIM LLC
New York
– -$10K -917 Closed
Osaic Holdings
38
Osaic Holdings
Arizona
– -$5.25K -513 -92%
JPLA
39
Joseph P. Lucia & Associates
New York
– -$1K -92 Closed
CAPTRUST Financial Advisors
40
CAPTRUST Financial Advisors
North Carolina
– +$31 +3 +14%
FCA
41
FinTrust Capital Advisors
South Carolina
– +$235 +23 New
1
2

COCP Hedge Fund Activity: Q4 2021 in Review

35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q4 2021, worth a combined $9.78M — down 39% from $16.1M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of COCP and 2 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 10 added.

The largest buyer was Sabby Management, adding an estimated $488K. The largest seller was Mariner, exiting entirely with an estimated $315K sold.

  • 35 institutional investors held Cocrystal Pharma (COCP) as of Q4 2021, down from 41 in Q3 2021.
  • Funds reported $9.78M of Cocrystal Pharma stock for Q4 2021, down 39% quarter-over-quarter.
  • 2 funds opened new Cocrystal Pharma positions in Q4 2021 and 8 closed out, a net change of -6 holders.
  • The largest Cocrystal Pharma buyer in Q4 2021 was Sabby Management, an estimated $488K added.
  • The largest Cocrystal Pharma seller in Q4 2021 was Mariner, an estimated $315K sold.

Based on aggregated 13F filings for Q4 2021.